From the Research
For Streptococcus anginosus urinary tract infections, penicillin is the first-line antibiotic treatment, typically prescribed as amoxicillin 500 mg three times daily for 7-10 days. This recommendation is based on the high susceptibility of S. anginosus to beta-lactam antibiotics, as reported in a study from 2020 1. Alternatives for penicillin-allergic patients include cephalexin 500 mg four times daily, or in cases of severe penicillin allergy, clindamycin 300-450 mg four times daily for the same duration.
Key Considerations
- For complicated infections or those with risk factors for treatment failure, amoxicillin-clavulanate 875/125 mg twice daily may be more appropriate, as suggested by a study from 2024 2 that evaluated the use of amoxicillin-clavulanate in urinary tract infections caused by ceftriaxone non-susceptible Enterobacterales.
- S. anginosus, part of the Streptococcus milleri group, can cause more invasive infections than typical UTI pathogens, so it is crucial to complete the full antibiotic course even if symptoms improve quickly.
- Adequate hydration and follow-up urine cultures after treatment completion are recommended to confirm eradication, as S. anginosus UTIs can sometimes lead to abscess formation if inadequately treated.
Additional Guidance
- A study from 2015 3 found that amoxicillin-clavulanic acid may be a good oral antimicrobial for the treatment of ESBL-positive UTIs, if the causative agent is susceptible to this antibiotic.
- However, some strains may develop resistance during therapy, especially in those exhibiting high AMC MICs.
- A review article from 2021 4 highlights the importance of early diagnosis and appropriate therapy with antibiotics in preventing complicated UTI conditions such as urosepsis.